Dr. Shardule Shah is the CEO and co-founder of Lime Therapeutics. In 2022, he was awarded the prestigious Harvard Blavatnik Fellowship for Life Sciences Entrepreneurship and currently holds an Executive Fellow position at Harvard Business School. Prior to co-founding Lime in 2021, Dr. Shah worked in the Bay Area at Lucira Health and Roche Molecular Diagnostics, where he managed cross-functional global clinical operations and regulatory affairs teams for point-of-care diagnostic devices including COVID-19 and influenza testing. Dr. Shah earned his PhD from Emory University in immunology, MBA from Harvard Business School, MS from the University of Pennsylvania in cell biology, and BS from Case Western Reserve University in biochemistry.